Overcoming resistance to single-agent therapy for oncogenic BRAF gene fusions via combinatorial targeting of MAPK and PI3K/mTOR signaling pathways

Pediatric low-grade gliomas (PLGGs) are frequently associated with activating BRAF gene fusions, such as KIAA1549-BRAF, that aberrantly drive the mitogen activated protein kinase (MAPK) pathway. Although RAF inhibitors (RAFi) have been proven effective in BRAF-V600E mutant tumors, we have previously...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Oncotarget
Glavni autori: Jain, Payal, Silva, Amanda, Han, Harry J., Lang, Shih-Shan, Zhu, Yuankun, Boucher, Katie, Smith, Tiffany E., Vakil, Aesha, Diviney, Patrick, Choudhari, Namrata, Raman, Pichai, Busch, Christine M., Delaney, Tim, Yang, Xiaodong, Olow, Aleksandra K., Mueller, Sabine, Haas-Kogan, Daphne, Fox, Elizabeth, Storm, Phillip B., Resnick, Adam C., Waanders, Angela J.
Format: Artigo
Jezik:Inglês
Izdano: Impact Journals LLC 2017
Teme:
Priority Research Paper
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5689567/
https://ncbi.nlm.nih.gov/pubmed/29156677
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.20949
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items